Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
EO2401 is a cancer vaccine comprising microbiome-derived immunogenic peptides that are similar to three tumor-associated antigens, potentially resulting in increased anti-tumor immune response against tumors expressing these antigens (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|EO2401 + Nivolumab||EO2401 Nivolumab||0||1|